Clinical Read2026-06-01

Ivonescimab with platinum-based chemotherapy compared with tislelizumab - (AK112-306/HARMONi-6)

Name: Ivonescimab with platinum-based chemotherapy compared with tislelizumab - (AK112-306/HARMONi-6)
Start: 2026-06-01

Summit Therapeutics Inc.SMMT

Indication: Locally advanced or metastatic squamous non-small cell lung cancer (NSCLC) irrespective of PD-L1 expression
Stage: phase3
Event: Phase 3